Do we think a fair estimate in value could be based on a multiplier of survival time compared to the existing medication Relivrio of 9 months and value of around $1B?
So if we get, say, 2 years survival the value of Monepantel (just for MND + minor side effects) should be around $2.6B
Based on SOI - 386,486,545
$2.60 = $1,004,865,017 MC
$5.20 = $2,009,730,034 MC
Do we think a fair estimate in value could be based on a...
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.015(8.82%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.5¢ | 17.5¢ | $336.6K | 1.885M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 23529 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 382502 | 4 |
View Market Depth
| Last trade - 13.19pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
0.015 ( 3.51 %) |
||||
| Open | High | Low | Volume | ||
| 17.5¢ | 18.5¢ | 17.5¢ | 1368293 | ||
| Last updated 13.09pm 13/05/2024 ? | |||||
| PAA (ASX) Chart |